Clinical implications of targeting VEGF in solid tumors

Area of Science:

• Oncology
• Medical Therapeutics

Background:

• Conventional chemotherapy has limited efficacy for metastatic diseases.
• Tumor angiogenesis, crucial for cancer growth, is driven by vascular endothelial growth factor (VEGF).

Purpose of the Study:

• To inform nurses about the clinical implications of VEGF-targeted therapies.
• To guide nurses on administration, patient education, and side-effect management for VEGF inhibitors.

Main Methods:

• Review of current literature on VEGF inhibitors in cancer treatment.
• Educational session design for healthcare professionals.

Main Results:

• VEGF inhibitors represent a novel therapeutic approach for metastatic cancers.
• Effective management requires specific nursing knowledge regarding administration and adverse events.

Conclusions:

• Targeting VEGF offers a promising strategy to improve outcomes in metastatic cancer.
• Nurses play a vital role in optimizing patient care and treatment success with VEGF inhibitors.